TNF and hepatocellular carcinoma: It must be considered that conventional treatments like biologics (e.g., TNF-α inhibitors) increase the risk of systemic immunosuppression, whilst the proposed topical treatment based on HCC + SH exhibit none/minimal side effects [41,42].